Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

BAFNA PHARMACEUTICALS LTD. - 532989 - Closure of Trading Window

 Pursuant to the provisions of SEBI(Prohibition of Insider Trading) Regulations, 2015, as amended, read with code of conduct for prohibition of insider trading of the Company the "Trading Window" for the designated persons, connected persons, and their immediate relatives to deal in the shares of the Company shall remain closed from Sunday, October 01, 2023, up to 48 hours after the declaration of Audited Financial Results of the Company by the Board for the quarter ending September 30, 2023 (both days inclusive).
29-09-2023
Bigul

BAFNA PHARMACEUTICALS LTD. - 532989 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 Scrutinizer''s Report and e-voting result of 28th Annual General Meeting of Bafna pharmaceuticals Limited for the FY 2022-23
25-09-2023
Bigul

BAFNA PHARMACEUTICALS LTD. - 532989 - Announcement under Regulation 30 (LODR)-Resignation of Director

 Shri Kamlesh Kumar Babulal, DIN: 01218959, vide his letter dated September 09, 2023, has resigned as Non-Executive Independent Director from the Board of Bafna Pharmaceuticals Limited with immediate effect on personal grounds. Shri Kamlesh Kumar Babulal was Chairperson of Nomination and Remuneration Committee and member of Audit Committee and Social Responsibility Committee of the Company.
23-09-2023
Bigul

BAFNA PHARMACEUTICALS LTD. - 532989 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 We wish to inform that 28th Annual General Meeting (AGM) of the Company was held today i.e., Friday, September 22, 2023, through Video Conferencing mode and business mentioned in the notice dated August 11, 2023, was transacted by the members of the Company. In this connection, we have enclosed summary of proceedings of the AGM as required under the Regulation 30 read with part A of Schedule III of SEBI (LODR) Regulations, 2015.
22-09-2023
Bigul

BAFNA PHARMACEUTICALS LTD. - 532989 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SRJR Lifesciences LLP
11-09-2023
Bigul

BAFNA PHARMACEUTICALS LTD. - 532989 - Filing Of Report Under Regulation 7(2)(B) Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations, 2015, As Amended ('SEBI Insider Trading Regulations')

 We here by submit the attached disclosure received under Regulation 7(2)(a) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, from SRJR Lifesciences LLP, one of the promoters of Bafna Pharmaceuticals Limited, ("the Company"), regarding disposal Equity shares of the Company. This submission is pursuant to Regulation 7(2)(b) of SEBI(Prohibition of Insider Trading) Regulations, 2015, as amended.
11-09-2023
Bigul

BAFNA PHARMACEUTICALS LTD. - 532989 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SRJR Lifesciences LLP
11-09-2023
Bigul

BAFNA PHARMACEUTICALS LTD. - 532989 - Notice of Offer for sale of shares by Promoter & Floor Price

 Notice of the proposed Offer for Sale of equity shares of face value of Rs. 10 each ("Equity Shares") of Bafna Pharmaceuticals Ltd (the "Company") by its Promoter, SRJR Lifesciences LLP, through the stock exchange mechanism (the "Notice")
06-09-2023
Bigul

BAFNA PHARMACEUTICALS LTD. - 532989 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Copies of the Newspaper publication ''Notice - Dispatch of notice of 28th Annual General Meeting, Annual Report 2022-23, Remote e-Voting instructions, and Cut-off date'' published in the Newspapers viz., Business Standard (English, all editions) and Makkal Kural(Tamil, Chennai edition) on August 31, 2023.
31-08-2023
Bigul

BAFNA PHARMACEUTICALS LTD. - 532989 - Reg. 34 (1) Annual Report.

 As informed in our letter referred above, the 28th Annual General Meeting (AGM) of the Company is scheduled to be held on Friday, September 22, 2023, at 10:25 a.m. through Video Conference/ Other Audio-Visual Means. We wish to confirm that the following documents have been circulated to the members by electronic mode, today, i.e., August 30, 2023, and we are submitting herewith the said documents for the financial year ended 2022-23, pursuant to Regulation 30 and 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. SEBI Circular No. SEBI/HO/CFD/PoD-2/P/CIR/2023/4 dated January 05, 2023: i. Notice of 28th Annual General Meeting (duly covering the instructions for remote e-Voting, e-voting during the meeting and instructions for attending the AGM through Video Conference). ii. Annual Report.
30-08-2023
Next Page
Close

Let's Open Free Demat Account